Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Bertolini

Showing results (21-30 of 187) with videos related to

Pageof 19
Sort By:
Biochimica Et Biophysica Acta|August 6, 2010
Cellular and soluble markers of tumor angiogenesis: from patient selection to the identification of the most appropriate postresistance therapyFrancesco Bertolini, Paola Marighetti, Yuval Shaked
Life (Basel, Switzerland)|November 27, 2021
New Insight to Overcome Tumor Resistance: An Overview from Cellular to Clinical TherapiesGiulia Mitola, Paolo Falvo, Francesco Bertolini
International Journal of Molecular Sciences|February 12, 2021
Cellular and Molecular Players in the Interplay between Adipose Tissue and Breast CancerFrancesca Reggiani, Paolo Falvo, Francesco Bertolini
The New England Journal of Medicine|December 20, 2005
Circulating endothelial progenitor cellsFrancesco Bertolini, Patrizia Mancuso, Robert S Kerbel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2014
About CD45-/CD31+/CD105+ circulating cells in patients with gynecologic malignancies--letterFrancesco Bertolini, Patrizia Mancuso, John V Heymach
Nature Reviews. Clinical Oncology|October 21, 2015
Drug repurposing in oncology--patient and health systems opportunitiesFrancesco Bertolini, Vikas P Sukhatme, Gauthier Bouche
Cancers|October 23, 2021
The Dual Role of Innate Lymphoid and Natural Killer Cells in Cancer. from Phenotype to Single-Cell Transcriptomics, Functions and Clinical UsesStefania Roma, Laura Carpen, Alessandro Raveane, et al.
Drug Discovery Today|August 8, 2012
Low-dose metronomic chemotherapy: from past experience to new paradigms in the treatment of cancerDavid Loven, Erez Hasnis, Francesco Bertolini, et al.
Cancers|July 12, 2025
Myeloid-Derived Suppressor Cells (MDSCs) at the Crossroad of Senescence and CancerGiovanna Talarico, Stefania Orecchioni, Paolo Falvo, et al.
Discovery Medicine|October 15, 2015
Mechanisms of obesity in the development of breast cancerStefania Orecchioni, Francesca Reggiani, Giovanna Talarico, et al.
Pageof 19

Showing results (21-30 of 187) with videos related to

Sort By:
Pageof 19
Biochimica Et Biophysica Acta|August 6, 2010
Cellular and soluble markers of tumor angiogenesis: from patient selection to the identification of the most appropriate postresistance therapyFrancesco Bertolini, Paola Marighetti, Yuval Shaked
Life (Basel, Switzerland)|November 27, 2021
New Insight to Overcome Tumor Resistance: An Overview from Cellular to Clinical TherapiesGiulia Mitola, Paolo Falvo, Francesco Bertolini
International Journal of Molecular Sciences|February 12, 2021
Cellular and Molecular Players in the Interplay between Adipose Tissue and Breast CancerFrancesca Reggiani, Paolo Falvo, Francesco Bertolini
The New England Journal of Medicine|December 20, 2005
Circulating endothelial progenitor cellsFrancesco Bertolini, Patrizia Mancuso, Robert S Kerbel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2014
About CD45-/CD31+/CD105+ circulating cells in patients with gynecologic malignancies--letterFrancesco Bertolini, Patrizia Mancuso, John V Heymach
Nature Reviews. Clinical Oncology|October 21, 2015
Drug repurposing in oncology--patient and health systems opportunitiesFrancesco Bertolini, Vikas P Sukhatme, Gauthier Bouche
Cancers|October 23, 2021
The Dual Role of Innate Lymphoid and Natural Killer Cells in Cancer. from Phenotype to Single-Cell Transcriptomics, Functions and Clinical UsesStefania Roma, Laura Carpen, Alessandro Raveane, et al.
Drug Discovery Today|August 8, 2012
Low-dose metronomic chemotherapy: from past experience to new paradigms in the treatment of cancerDavid Loven, Erez Hasnis, Francesco Bertolini, et al.
Cancers|July 12, 2025
Myeloid-Derived Suppressor Cells (MDSCs) at the Crossroad of Senescence and CancerGiovanna Talarico, Stefania Orecchioni, Paolo Falvo, et al.
Discovery Medicine|October 15, 2015
Mechanisms of obesity in the development of breast cancerStefania Orecchioni, Francesca Reggiani, Giovanna Talarico, et al.
Pageof 19